Search clinical trials for: complete cytoreductive surgery plus HIPEC with Mytomicin C for 90 minutes

Total 10 results

Hospital Universitario de Fuenlabrada
Instituto de Investigación Hospital Universitario La Paz

Recruiting

Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) (GECOP-MMC)

Colon Cancer | Peritoneal Carcinomatosis

Spain
Baki Topal
Universitaire Ziekenhuizen KU Leuven

Terminated

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

Gastrointestinal Cancer | Peritoneal Carcinomatosis

Belgium
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine; University of Miami; The Cleveland... and other collaborators

Active, not recruiting

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis (ICARuS)

Colorectal Cancer | Appendix Cancer

United States
Wuhan University
NPO Organization to Support Peritoneal Dissemination Treatment; Kishiwada Tokushukai... and other collaborators

Unknown

Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis (IPHC)

Stomach Neoplasms | Neoplasm Metastasis | Colorectal Neoplasms | Mesothelioma

China
Rocky Mountain Cancer Centers

Unknown

Definitive Therapy for Oligometastatic Solid Malignancies

Stage IV or Recurrent Carcinoma or Sarcoma

United States
UNICANCER

Terminated

Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

Colorectal Cancer | Metastatic Cancer | Primary Peritoneal Cavity Cancer

France, Belgium
Memorial Sloan Kettering Cancer Center

Completed

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

Thyroid Cancer | Papillary Microcarcinoma

United States
Yanhong Deng

Recruiting

Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer (FOBEAR)

Rectal Cancer

China
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Peritoneal Carcinomatosis | Stage IV Uterine Corpus Cancer AJCC v8 | Stage IVA Uterine Corpus Cancer AJCC v8 | Stage IVB Uterine Corpus Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Malignant Uterine Neoplasm | Clinical Stage IV Gastric Cancer AJCC v8 | Metastatic Colorectal Carcinoma | Stage... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study)

Stage III Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma

United States

Search clinical trials for: complete cytoreductive surgery plus HIPEC with Mytomicin C for 90 minutes

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations